Back to search

University of Dundee

Assessment of <i>N</i>-myristoyltransferase and the <i>N</i>-myristoylomeas a potential chemotherapeutic target in<i>Trypanosoma cruzi</i>

Abstract

dc:description.abstract

As there is a need for fully validated drug targets in <i>Trypanosoma cruzi</i>, the genetic andbiochemical essentiality of <i>N</i>-myristoyltransferase (NMT) was assessed. The geneticrequirement was assessed using a classical gene replacement strategy, attempting tosequentially replace the endogenous alleles with drug resistance genes to generate an<i>NMT</i> null parasite. It was only possible to achieve this in the presence of an ectopiccopy of <i>NMT</i> under constitutive expression, providing the strongest evidence that thisgene is essential for the proliferation of the epimastigote. While both NMT and <i>N</i>-myristoylationwere detected in all lifecycle stages, there were subtle differences in theexpression of several myristoylated proteins. However, at least ~10 myristoylatedproteins were common throughout the lifecycle. In addition, <i>N</i>-myristoylation in thisparasite was found to be primarily associated with nascent protein synthesis, astreatment with cycloheximide reduced the number of <i>N</i>-myristoylated proteins detected.The sensitivity of epimastigotes to the inhibitor DDD85646 correlated with theexpression of NMT, suggesting it to be the target in the parasite. This was confirmedby the dose-dependent depletion of <i>N</i>-myristoylated proteins detected in parasitestreated with this compound. Mechanism of action studies revealed a cytokinesis defectcaused by the inhibition of <i>N</i>-myristoylation and NMT. Overexpression of NMT wasable to rescue these cells from this phenotype confirming that it is NMT mediated. The<i>N</i>-myristoylated proteins comprising the <i>N</i>-myristoylome of the epimastigote wereidentified using the myristic acid analog, azidomyristate and a chemical proteomicsapproach. Combining label-free and SILAC methodologies, 38 proteins were enrichedfrom azidomyristate labelled cells, 35 of which were predicted to have a glycine afterthe initial methionine. The findings from these experiments have led to the mostcomprehensive <i>N</i>-myristoylome of <i>T. cruzi</i> studied to date and provide severalhypotheses, by which the inhibition of NMT leads to the observed cytokinesis defect.

Degree

thesis:*
Name dc:type.qualificationname
Doctor of Philosophy
Level dc:type.qualificationlevel
Doctoral Thesis
Grantor dc:publisher.institution
University of Dundee
Year dc:date.issued
2014

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Roberts, Adam
Advisor dc:contributor.advisor
  • Fairlamb, Alan

Subjects

dc:subject × 7

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
oai:discovery.dundee.ac.uk:studenttheses/0751872a-abe8-4de0-86f6-5f26fe9ab6e4
OAI identifier oai:identifier
oai:discovery.dundee.ac.uk:studenttheses/0751872a-abe8-4de0-86f6-5f26fe9ab6e4

Chain of custody

source
Harvested from
University of Dundee
Base URL
discovery.dundee.ac.uk/ws/oai
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Roberts, Adam. Assessment of <i>N</i>-myristoyltransferase and the <i>N</i>-myristoylomeas a potential chemotherapeutic target in<i>Trypanosoma cruzi</i>. Doctoral Thesis thesis, University of Dundee, 2014. https://discovery.dundee.ac.uk/en/studentTheses/0751872a-abe8-4de0-86f6-5f26fe9ab6e4